Role of Bilirubin, Vitamin C and Ceruloplasmin as antioxidants in coronary artery disease [CAD]

Indian Journal of Clinical Biochemistry

Volumn 20, Issue 2, 2005, Pages 68-74

  Verma, V K ^a   Ramesh, V ^a   Tewari, Satyendra ^a   Gupta, R K ^a   Sinha, Nakul ^a   Pandey, C M ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidants; Bilirubin; CAD; Ceruloplasmin; Role; Serum Levels; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BILIRUBIN; CERULOPLASMIN; CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CERULOPLASMIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 24044491927     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02867403     Document Type: Article

References (21)

1. Stringer, M.D., Gorog, P.G., Freeman, A. and Kakkar, V.V. (1989) Lipid peroxides and atherosclerosis. Br. Med. J. 298, 281-284.
2. Poulter, N., Sever, P. and Thom, S. eds (1993) Cardiovascular disease: risk factors and intervention. Oxford: Radcliffe Medical Press, 351 pp.
3. Halliwell, B. (1994) Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 344: 721-724.
4. Hennekens, C.H. and Gaziano, J.M. (1993) Antioxidants and heart disease: epidemiology and clinical evidence. Clin. Cardiol. 16 (suppl 1), 1110-1113.
5. Schwertner, H.A., Jackson, W.G. and Tolan, G. (1994) Association of low serum bilirubin with increased risk of coronary artery disease. Clin. Chem. 40(1), 18-23.
6. Breimer, L.H., Wanna, Methee G., Ebrahim, S. and Shaper, A.G. (1995) Serum bilirubin and risk of ischemic heart disease in middle aged British men. Clin. Chem. 41 (10), 1504-1508.
7. Atansiu, R.L., Stea, D., Mateescu, M., et al. (1998) Direct evidence of ceruloplasmin antioxidant properties. Mol. Cell Biochem. 189, 127-135.
8. Holmberg, C. and Laurell, C. (1951) Investigations in serum copper III. Ceruloplasmin as an enzyme. Acta. Chem. Scand. 5, 476-481.
9. Osaki, S., Johnson, D. and Frieden, E. (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241, 2746-2751.
10. Enstrom, J.E., Kanim, L.E. and Klein, M.A. (1992) Vitamin C intake and mortality among a sample of the United States Population. Epidemiology 3, 194-202.
11. Nyyssonen, K., Parviainen, M.T., Salonen, R. et al. (1997) Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. Br. Med. J. 314, 634-638.
12. Doumas, B., et al. (1985) Candidate reference method for determination of total bilirubin in serum: Development and validation. Clin. Chem. 31, 1779-1789.
13. Gowenlock, A.M., ed. (1988) Varley's practical clinical biochemistry, Heinemann Medical Books, London, Sixth Edition, 927 pp.
14. Ravin, H.A. (1961) An improved colorimetric enzymatic assay of ceruloplasmin. J. Lab. Med. 58, 161-168.
15. Jialal, I. and Devaraj, S. (1966) Low density lipoprotein oxidation, antioxidants and atherosclerosis: a clinical biochemistry perspective. Clin. Chem. 42, 498-506.
16. Mateeseu, M., Chahine, R., Roger, S. and Atanasiu, R. (1995) Protection of myocardical tissue against deleterious effects of oxygen free radicals by ceruloplasmin, Arzneim Forsch/drug Res. 45, 476-480.
17. Atanasiu, Chahine R., Mateeseu, M. and Nadeau, R. (1995) The antiarrhythmic effects of ceruloplasmin during reperfusion of ischaemic isolated rat heart. Can. J. Physiol. Pharmaacol. 73, 1253-1261.
18. Heinecke, J.W. 1997) Mechanism of oxidative damage of low density lipoproteins in human atherosclerosis. Curr. Opin. Lipidol. 8, 268-274.
19. Verlangieri, A.J. and Bush, M.J. (1992) Effects of d-alpha tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11, 131-138.
20. Esterbauer, H., Pull Diebar-Rotheneder, M., et al. (1991) Effects of anti-oxidants on oxidative modification of LDL. Ann. Med. 23, 573-581.
21. Gey, K.G., Puska, P., Jordon, P., et al. (1991) Inverse correlation between Vitamin E and mortality from ischemic heart disease in cross cultural epidemiology. Am. J. Clin. Nutr. 53, S326-334.